Smoking and Risk of Colorectal Cancer Sub-Classified by Tumor-Infiltrating T Cells

scientific article published on 01 January 2019

Smoking and Risk of Colorectal Cancer Sub-Classified by Tumor-Infiltrating T Cells is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/JNCI/DJY137
P932PMC publication ID6335108
P698PubMed publication ID30312431

P50authorShuji OginoQ18055035
Edward L. GiovannucciQ20740896
Nana KeumQ10855685
Yin CaoQ40619083
Annacarolina da SilvaQ59824519
Mingyang SongQ61307934
Charles S. FuchsQ88762246
Tsuyoshi HamadaQ89223117
Jeffrey A MeyerhardtQ89850327
David A. DrewQ89874424
Kosuke MimaQ90763902
Kana WuQ93166670
Reiko NishiharaQ95974375
Katsuhiko NoshoQ113460216
Jonathan A NowakQ114578182
Keisuke KosumiQ114578184
Marios GiannakisQ114578217
Tyler S TwomblyQ114578236
P2093author name stringLi Liu
Xuehong Zhang
Yan Shi
Andrew T Chan
Molin Wang
Yohei Masugi
Wanwan Li
Mancang Gu
P2860cites workMolecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary fieldQ24620628
Effects of Alcohol on Tumor Growth, Metastasis, Immune Response, and Host SurvivalQ26773212
DNA methylation changes of whole blood cells in response to active smoking exposure in adults: a systematic review of DNA methylation studiesQ26781964
Immune Checkpoint Blockade in Cancer TherapyQ26830509
Aspirin and the risk of colorectal cancer in relation to the expression of COX-2.Q27851408
Mutational signatures associated with tobacco smoking in human cancerQ28005544
Impacts of cigarette smoking on immune responsiveness: Up and down or upside down?Q28072341
Immune checkpoint blockade: a common denominator approach to cancer therapyQ28083981
Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectumQ28262150
PD-1 Blockade in Tumors with Mismatch-Repair DeficiencyQ28262647
Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survivalQ28277824
Statistical methods for studying disease subtype heterogeneityQ28385063
Molecular pathological epidemiology: new developing frontiers of big data science to study etiologies and pathogenesis.Q30244608
Nicotinic receptor β2 determines NK cell-dependent metastasis in a murine model of metastatic lung cancer.Q30457614
Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sampleQ33383866
Cigarette smoking and colorectal cancer risk by molecularly defined subtypesQ34042268
Cigarette smoking and variations in systemic immune and inflammation markersQ34354166
Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature reviewQ34551974
Association between molecular subtypes of colorectal cancer and patient survivalQ34759064
The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpointsQ34943776
A Meta-Regression Method for Studying Etiological Heterogeneity Across Disease Subtypes Classified by Multiple Biomarkers.Q35896952
Mismatch Repair and Colon Cancer: Mechanisms and Therapies ExploredQ35955233
Predictors of immunosuppressive regulatory T lymphocytes in healthy womenQ36206608
The consensus molecular subtypes of colorectal cancerQ36258187
Cancer immunopreventionQ36723234
Genomic Correlates of Immune-Cell Infiltrates in Colorectal CarcinomaQ36850230
A prospective study of duration of smoking cessation and colorectal cancer risk by epigenetics-related tumor classificationQ36974863
Transforming Cancer Prevention through Precision Medicine and Immune-oncology.Q37114360
CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancerQ37185561
Long-term colorectal-cancer incidence and mortality after lower endoscopyQ37341827
Associations between smoking, alcohol consumption, and colorectal cancer, overall and by tumor microsatellite instability statusQ37382206
Lymphocytic reaction to colorectal cancer is associated with longer survival, independent of lymph node count, microsatellite instability, and CpG island methylator phenotypeQ37407802
Tobacco smoking and methylation of genes related to lung cancer developmentQ37644809
Effects of tobacco smoke on immunity, inflammation and autoimmunityQ37665006
Prevention and treatment of cancers by immune modulating nutrients.Q38718929
From tumour heterogeneity to advances in precision treatment of colorectal cancerQ38786707
Nicotine enhances invasion and metastasis of human colorectal cancer cells through the nicotinic acetylcholine receptor downstream p38 MAPK signaling pathwayQ38822461
A Prospective Study of Smoking and Risk of Synchronous Colorectal CancersQ39002395
Fusobacterium nucleatum in Colorectal Carcinoma Tissue According to Tumor LocationQ39217446
Immunotherapy for colorectal cancer: where are we heading?Q39218636
Nutrition, inflammation and cancerQ39443978
The immune contexture in cancer prognosis and treatmentQ39456999
Association Between Inflammatory Diet Pattern and Risk of Colorectal Carcinoma Subtypes Classified by Immune Responses to Tumor.Q40060444
Cigarette smoke impairs NK cell-dependent tumor immune surveillance.Q40187321
Cytotoxic T Cells and Granzyme B Associated with Improved Colorectal Cancer Survival in a Prospective Cohort of Older WomenQ40423175
Tumor-Infiltrating Lymphocytes, Crohn's-Like Lymphoid Reaction, and Survival From Colorectal CancerQ40757402
Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite InstabilityQ40850728
Effects of cigarette smoke extract on primary activated T cellsQ41896875
The immune score as a new possible approach for the classification of cancerQ42539190
Connections of nicotine to cancerQ46056361
Meta-analysis of prospective cohort studies of cigarette smoking and the incidence of colon and rectal cancersQ46965853
Lifestyle, Diet, and Colorectal Cancer Risk According to (Epi)genetic Instability: Current Evidence and Future Directions of Molecular Pathological EpidemiologyQ47138060
Alcohol, smoking and the risk of premalignant and malignant colorectal neoplasmsQ47590767
Implications of the tumor immune microenvironment for staging and therapeuticsQ47592007
Colorectal cancer prevention: Immune modulation taking the stageQ49391998
Lifestyle factors and risk of sporadic colorectal cancer by microsatellite instability status: A systematic review and meta-analyses.Q50041618
Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicineQ50043586
Evolving notions on immune response in colorectal cancer and their implications for biomarker development.Q50098505
Metabolomic profiles of current cigarette smokersQ50286187
Biomarker Tests for Molecularly Targeted Therapies--The Key to Unlocking Precision Medicine.Q51275924
Applying Cox Regression to Competing RisksQ52339900
Smoking Cessation, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology.Q53134015
Colorectal cancerQ89218269
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectcolorectal cancerQ188874
P304page(s)42-51
P577publication date2019-01-01
P1433published inJournal of the National Cancer InstituteQ400279
P1476titleSmoking and Risk of Colorectal Cancer Sub-Classified by Tumor-Infiltrating T Cells
P478volume111